( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1559.3
1313.3
1338.1
1534.6
Total Expenditure
1538.5
1419.2
1400.7
1610
PBIDT (Excl OI)
20.8
-105.9
-62.60
-75.40
Other Income
8.8
7.7
33.1
15.6
Operating Profit
29.59
-98.19
-29.5
-59.8
Exceptional Items
NA
-46
NA
NA
PBDT
-26.90
-214.7
-94.4
-121.3
Depreciation
51.4
51.8
47
45.4
Profit Before Tax
-78.30
-266.5
-141.4
-166.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-73.90
-266.5
-141.4
-166.7
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-73.90
-266.5
-141.4
-166.7
Minority Interest
NA
NA
NA
NA
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-73.9
-266.5
-141.4
-166.7
Equity Capital
167.4
167.4
167.4
167.4
Calculated EPS
-0.88
-3.18
-1.68
-1.99
Calculated EPS (Annualised)
-3.53
-12.73
-6.75
-7.96
No of Public Share Holdings
20961527
20960027
20960027
20960027
% of Public Share Holdings
25.04
25.04
25.04
25.04
PBIDTM% (Excl OI)
1.33
-8.06
-4.67
-4.91
PBIDTM%
1.89
-7.47
-2.20
-3.89
PBDTM%
-1.72
-16.34
-7.05
-7.90
PBTM%
-5.02
-20.29
-10.56
-10.86
PATM%
-4.73
-20.29
-10.56
-10.86